Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Hypertrophic cardiomyopathy (HCM) is a genetic disorder characterised by increased arrhythmic risk. The causes are still unclear, but potential pro-arrhythmic mechanisms may include increased temporal and spatial variability in action potential duration (APD) as well as repolarisation abnormalities, such as early afterdepolarisations (EADs) and APD alternans. We performed investigations of these pro-arrhythmic mechanisms and their modulation by late sodium current (INaL) inhibition, in two populations of healthy (CTRL) and HCM human endocardial action potential (AP) models, calibrated against human experimental recordings of AP and Ca2+ transient (CaT) in single cells. The simulated HCM phenotype was in agreement with the experimental observations, showing prolonged AP and CaT, together with an increase in their variability. In addition, simulation results show that HCM promotes EADs and APD alternans at rapid pacing rates. Their occurrence is counteracted by INaL inhibition, suggesting this as a good therapeutic target in HCM.


Conference paper

Publication Date





861 - 864